MedPath

Prevalence and Impact on Quality of Life of Lower Urinary Tract Symptoms (LUTS) in Night Workers

Conditions
To Evaluate Lower Urinary Tract Symptoms (LUTS) and Their Impact on Quality of Life in Night Workers
Registration Number
NCT04124874
Lead Sponsor
Jagiellonian University
Brief Summary

The first large population-based study to evaluate lower urinary tract symptoms and their impact on quality of life in night workers.

Detailed Description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) and their impact on quality of life in night workers. The study objective is to assess the prevalence and bother of LUTS in the population of night workers.

This study will be conducted as a questionnaire survey with assessment of LUTS using a standardized protocol based on definitions by the International Continence Society (ICS). The International Prostate Symptom Score (IPSS), the Overactive Bladder- Validated 8-question Screener (OAB-V8), the Patient Health Questionnaire-9 (PHQ-9), the Athen Insomnia Scale, the Work Productivity and Activity Impairment Questionnaire (WPAI), the 12-Item Short Form Health Survey (SF-12) questionnaires will be included. Participants will be also asked to rate how often they experienced individual LUTS and the degree of associated bother.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10000
Inclusion Criteria

Night workers defined as any workers, who, during night time, work at least three hours of their daily working time as a normal course or who work at night at least 1/4 of their working time during the accounting period (definition by the Polish Labour Code).

Exclusion Criteria

Non night workers Urinary tract infection in the past 4 weeks

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom bother of LUTSThrough study completion, an average of 3 months

The degree of associated bother will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).

Prevalence of LUTSThrough study completion, an average of 3 months

The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).

Secondary Outcome Measures
NameTimeMethod
Work productivityThrough study completion, an average of 3 months

The work productivity will be assessed with the Work Productivity and Activity Impairment Questionnaire (WPAI).

Prevalence of specific lower urinary tract symptomsThrough study completion, an average of 3 months

The prevalence of specific lower urinary tract symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms).

Sleep qualityThrough study completion, an average of 3 months

The sleep quality will be assessed with the Athen Insomnia Scale questionnaire.

General quality of lifeThrough study completion, an average of 3 months

The general quality of life will be assessed with the 12-Item Short Form Health Survey (SF-12).

Prevalence of depressive symptomsThrough study completion, an average of 3 months

The prevalence of depressive symptoms will be assessed with the PHQ-9 (Patient Health Questionnaire-9).

Symptom bother of specific lower urinary tract symptomsThrough study completion, an average of 3 months

The degree of associated bother of specific lower urinary tract symptoms will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).

Prevalence of OABThrough study completion, an average of 3 months

The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB- V8) questionnaire.

Trial Locations

Locations (1)

Department of Urology Jagiellonian University

🇵🇱

Krakow, Poland

© Copyright 2025. All Rights Reserved by MedPath